Results 11 to 20 of about 1,343,260 (212)

On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding

open access: yesMedicine in Drug Discovery
Orexin receptor antagonists are on the market or under development for the treatment of insomnia and a number of other neuropsychiatric disorders. Currently, suvorexant, lemborexant and daridorexant, three dual orexin receptor antagonists (DORAs) have ...
Daniel Hoyer, Laura H. Jacobson
doaj   +4 more sources

Orexin Directly Excites Orexin Neurons through Orexin 2 Receptor [PDF]

open access: yesThe Journal of Neuroscience, 2010
Orexin neurons (hypocretin neurons) have a critical role in the regulation of sleep/wakefulness, especially in the maintenance of arousal. Here, we revealed that orexin neurons are directly and indirectly activated by orexin via the orexin 2 receptor (OX2R).
Akihiro, Yamanaka   +4 more
openaire   +3 more sources

Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B [PDF]

open access: yesJournal of Endocrinology, 2006
Orexin-A and orexin-B, via their receptors orexin-1 receptor (OX1R) and orexin-2 receptor (OX2R) have been shown to play a role in the regulation of feeding, body weight, and energy expenditure. Adipose tissue also contributes significantly to the maintenance of body weight by interacting with a complex array of bioactive peptides;
J E, Digby   +5 more
openaire   +3 more sources

Orexin-A increases the differentiation of human olfactory sensory neurons through orexin receptor type 1

open access: yesRegenerative Therapy
Introduction: Sensorineural olfactory dysfunction significantly impairs the life quality of patients but without effective treatments to date. Orexin is a neurotrophic factor activates neuronal network activity.
Yin-Tzu Chen   +5 more
doaj   +2 more sources

Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity. [PDF]

open access: yesPLoS ONE, 2017
Two promising lead structures of small molecular orexin receptor agonist have been reported, but without detailed analyses of the pharmacological properties.
Ainoleena Turku   +5 more
doaj   +5 more sources

The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking. [PDF]

open access: yesPLoS ONE, 2017
The orexin/hypocretin system is important for appetitive motivation towards multiple drugs of abuse, including nicotine. Both OX1 and OX2 receptors individually have been shown to influence nicotine self-administration and reinstatement.
Shaun Yon-Seng Khoo   +2 more
doaj   +3 more sources

Presence of orexin A and orexin 1 receptor in the buffalo prostate

open access: yesItalian Journal of Animal Science, 2010
The orexins A and B are two peptides discovered initially in the rat lateral hypothalamus involved in the regulation of some body functions such as food intake, sleep/wake cycle, arterial pressure and heart rate. They interact with two receptors defined &
A. Vittoria, F. Russo, G. Petrosino
doaj   +2 more sources

OX1 and OX2 orexin/hypocretin receptor pharmacogenetics [PDF]

open access: yesFrontiers in Neuroscience, 2014
Orexin/hypocretin peptide mutations are rare in humans. Even though human narcolepsy is associated with orexin deficiency, this is only extremely rarely due to mutations in the gene coding prepro-orexin, the precursor for both orexin peptides.
Miles Douglas Thompson   +5 more
doaj   +2 more sources

Differential Roles of Each Orexin Receptor Signaling in Obesity

open access: yesiScience, 2019
Summary: Orexins are hypothalamic neuropeptides that regulate feeding, energy expenditure, and sleep. Although orexin-deficient mice are susceptible to obesity, little is known about the roles of the orexin receptors in long-term energy metabolism. Here,
Miyo Kakizaki   +9 more
doaj   +2 more sources

Thymosin Alpha-1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis. [PDF]

open access: yesAdv Sci (Weinh)
In this study, we unveil a thymus‐brain endocrine axis wherein Tα1 engages HCRTR1 to inhibit RIPK3‐mediated necroptosis. This study nominates the Tal‐HCRTR1‐RIPK3 axis as a potent and clinically translatable therapeutic target for stroke and neurodegeneration.
Kang X   +11 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy